TIDES Europe: Oligonucleotide and Peptide Therapeutics
15-18 Nov 2022
David Ricketts, Director of Business Development CDMO, will attend the conference.
Flanders Investment & Trade at Wetenschapspark Universiteit Antwerpen
28 September 2022
Bernard Sagaert, interim CEO, will present eTheRNA’s experience in the process of the investment by Grandpharma from 14.00-14.30 CET.
LNP Formulation & Process Development Summit Boston, MA, USA
12-14 April 2022
George Dakwar, Senior Scientist of Drug Product Development, attended as speaker.
David Ricketts, Director of Business Development, CDMO attended the conference.